Tirzepatide Clinics in Des Moines, Washington
Compare Tirzepatide providers in Des Moines, Washington. Check ratings, telehealth availability, and insurance acceptance to find the right prescriber.
Tirzepatide Providers in Des Moines
Better Body Medical Weight Loss & Wellness Clinic
About Tirzepatide
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist developed by Eli Lilly. It uniquely targets both the GIP and GLP-1 receptors, producing greater weight loss and blood sugar control than GLP-1-only medications. Approved as Mounjaro for type 2 diabetes (2022) and Zepbound for weight management (2023), tirzepatide has shown weight loss of up to 22.5% in clinical trials — the highest of any GLP-1 class medication.
Expected Weight Loss
In the SURMOUNT-1 trial, participants on tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks. At the 10 mg dose, average weight loss was 21.4%. Over a third (36%) on the highest dose lost 25% or more of their body weight, and 63% lost 20% or more.
Cost
Without insurance, Tirzepatide typically costs $1,000-$1,200/month (Mounjaro), $1,000-$1,100/month (Zepbound). With insurance, costs range from $25-$200/month (varies by plan).
Frequently Asked Questions
There are 1 clinics prescribing Tirzepatide (Mounjaro and Zepbound) in Des Moines, Washington listed on GlobalGLP1.com.
Yes, 1 out of 1 Tirzepatide clinics in Des Moines offer telehealth consultations.
Tirzepatide costs in Des Moines vary by clinic and insurance. Without insurance, expect $800-$1,400/month. With insurance, copays range from $25-$200/month. Contact clinics directly for current pricing.
Most GLP-1 clinics in Des Moines do not require a referral. You can schedule a consultation directly. The provider will evaluate your eligibility based on BMI, medical history, and treatment goals.